Growth Metrics

Odyssey Health (ODYY) Non-Current Debt (2020 - 2026)

Odyssey Health's quarterly Non-Current Debt came in at $25000.0 in Q1 2026, little changed year-on-year from $25000.0 in Q1 2025, and little changed quarter-over-quarter from $25000.0 in Q3 2025.

Odyssey Health has reported Non-Current Debt for 7 years, with the latest figure at $25000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Debt changed 0.0% year-over-year to $25000.0; the trailing twelve-month figure through Jan 2026 stood at $25000.0 (changed 0.0% YoY), and the FY2025 full-year result was $25000.0, changed 0.0% from the prior year.
  • Non-Current Debt for Q1 2026 stood at $25000.0, roughly flat from $25000.0 in the prior quarter.
  • The five-year high for Non-Current Debt was $25000.0 in Q1 2022, with the low at $25000.0 in Q1 2022.
  • Average Non-Current Debt over 5 years is $25000.0, with a median of $25000.0 recorded in 2022.
  • Year-over-year, Non-Current Debt sank 50.0% in 2022 and changed 0.0% in 2023.
  • Tracing ODYY's Non-Current Debt over 5 years: stood at $25000.0 in 2022, then changed by 0.0% to $25000.0 in 2023, then changed by 0.0% to $25000.0 in 2024, then changed by 0.0% to $25000.0 in 2025, then changed by 0.0% to $25000.0 in 2026.
  • The last three Non-Current Debt figures came in at $25000.0 (Q1 2026), $25000.0 (Q3 2025), and $25000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 29.64 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.22 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 27.88 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.81 Bn
10 Odyssey Health - - - 25,000.00

Historic Data

Download Data 🔒
DateValue
Jan 31, 2026 25,000.00
Jan 31, 2026 25,000.00
Jul 31, 2025 25,000.00
Jul 31, 2025 25,000.00
Apr 30, 2025 25,000.00
Apr 30, 2025 25,000.00
Jan 31, 2025 25,000.00
Jan 31, 2025 25,000.00
Oct 31, 2024 25,000.00
Oct 31, 2024 25,000.00
Jul 31, 2024 25,000.00
Jul 31, 2024 25,000.00
Oct 31, 2023 25,000.00
Oct 31, 2023 25,000.00
Jul 31, 2023 25,000.00
Jul 31, 2023 25,000.00
Oct 31, 2022 25,000.00
Oct 31, 2022 25,000.00
Jul 31, 2022 25,000.00
Jul 31, 2022 25,000.00
Apr 30, 2022 25,000.00
Apr 30, 2022 25,000.00
Jan 31, 2022 25,000.00
Jan 31, 2022 25,000.00
Jan 31, 2021 50,000.00
Jan 31, 2021 50,000.00
Oct 31, 2020 50,000.00
Oct 31, 2020 50,000.00
Jul 31, 2020 50,000.00
Jul 31, 2020 50,000.00